Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Breast cancer screening marker composition, selection method thereof and breast cancer screening kit

A breast cancer and composition technology, which is applied in the field of breast cancer screening kits, breast cancer screening marker compositions and its selection, can solve the problems of time-consuming, inaccurate detection, cumbersome breast cancer screening operations, etc. Effects of shortening time, reducing mortality, and improving inspection sensitivity

Pending Publication Date: 2022-01-28
杭州求臻医学检验实验室有限公司
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The main purpose of the present invention is to provide a breast cancer screening marker composition, which aims to solve the problems of cumbersome, time-consuming and inaccurate detection of breast cancer screening in the prior art

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Breast cancer screening marker composition, selection method thereof and breast cancer screening kit
  • Breast cancer screening marker composition, selection method thereof and breast cancer screening kit
  • Breast cancer screening marker composition, selection method thereof and breast cancer screening kit

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0071] 1. Take 5mL of plasma, and use Qiagen plasma cell-free DNA extraction kit (Cat: 55204) to extract cfDNA.

[0072] 2. Take 20ng of extracted cfDNA and HinP1I (Cat: R0124, NEB), HpaII (Cat: R0171, NEB), AciI (Cat: R0551, NEB), HpyCH4IV (Cat: R0619, NEB) four methylation-sensitive endogenous Dicer (final concentration 10U / μL), 20 μL of the system, incubated at 37°C for 16h, inactivated at 80°C for 20min, and cut the background DNA.

[0073] 3. Use all the products after incubation as templates, add the above-mentioned 5 pairs of target-specific primers (50nM each) and 1 pair of internal reference primers (10nM), configure the system for multiplex PCR, and perform 8 cycles to obtain multiplex PCR products. The multiplex PCR reaction program is: 98°C / 45 9; 8cycle9 (98°C / 15 9, 55°C / 309, 72°C / 30 9)s 72°C / 1mins 4°C / hols.

[0074] 4. Take 1 μL of the multiplex PCR product in step 3 as a template, add the above 5 pairs of target-specific primers (0.25 μM each), and the correspon...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Sensitivityaaaaaaaaaa
Login to View More

Abstract

The invention provides a breast cancer screening marker composition, a selection method thereof and a breast cancer screening kit, and relates to the technical field of in-vitro diagnosis. According to the technical scheme, the breast cancer screening marker composition is hypermethylated in breast cancer and hypomethylated in white blood cells, and has a methylation sensitive incision enzyme digestion site; by utilizing the characteristic that methylation sensitive incision enzyme cannot cut methylation sites, non-tumor-source cfDNA is degraded, and tumor-source ctDNA is specifically amplified, so that the detection sensitivity is greatly improved; and the marking composition is small in quantity, simple to operate and short in time consumption. The breast cancer is detected and checked more accurately and effectively, so that the death rate of the breast cancer is reduced, and damage of the breast cancer to women is reduced.

Description

technical field [0001] The invention relates to the technical field of in vitro diagnosis, in particular to a breast cancer screening marker composition, a selection method thereof, and a breast cancer screening kit. Background technique [0002] Breast cancer is the most common malignant tumor in women. Epidemiology shows that the prevalence of breast cancer is on the rise. It has become a common and frequently-occurring disease that seriously affects women's physical and mental health and even threatens their lives. In recent years, it has surpassed cervical cancer as the most common disease among women. The malignant tumor with the highest incidence rate is the number one killer of women's health. In the prior art, the 21-gene detection method is usually used for breast cancer detection and prognosis judgment. However, the 21-gene detection method involves many genes, and the operation is cumbersome, time-consuming, and the detection is not accurate enough. Contents of ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6886C12N15/11
CPCC12Q1/6886C12Q2600/154
Inventor 张怡然段小红杨春燕宋莹莹王冰王东亮
Owner 杭州求臻医学检验实验室有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com